Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office

Oak Brook, Illinois (PRWEB) June 30, 2015

Aespala Medspa and Plastic Surgery is proud to introduce the newest member of their health care team, board-certified plastic surgeon Dr. David Dreyfuss.

Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing a General Surgery residency at Michael Reese Hospital in Chicago, followed by a Plastic Surgery Fellowship at the University of Chicago. He has taught and practiced medicine in the Chicago area for more than 25 years, and Aespala Medspa and Plastic Surgery is excited to add him as a major asset to the practice.

Years of experience and incredible results have earned Dr. Dreyfuss membership in the American Society of Plastic Surgery and the Illinois Plastic Surgery Society. He is also a Fellow in the American College of Surgeons. His peers recognize him as an expert in the field of cosmetic surgery and he has presented at many national meetings on breast surgery and breast implants.

"I have dedicated my life to the idea of high quality surgical care, personalized service, and beautiful aesthetic results," says Dr. Dreyfuss. "I am excited to join Dr. Michael Marschall in providing Aespala's patients with the highest quality of care and outstanding results." His compassion and dedication to the practice of medicine make Dr. Dreyfuss a perfect addition to Aespala Medspa and Plastic Surgery in Oak Brook, Illinois.

About Aespala MedSpa & Plastic Surgery
Aespala provides the latest, most advanced Chicago cosmetic surgery and medical spa treatments with advanced non- and minimally invasive technology. Whether you seek radiant, younger-looking skin or a slimmer, trimmer figure in a tranquil and sophisticated setting, Aespala in Oak Brook, IL can help refresh and renew your entire appearance.

About Dr. Michael A. Marschall
Dr. Michael A. Marschall, M.D., F.A.C.S., is a renowned, highly respected board-certified Chicago plastic surgeon now practicing in Oak Brook, IL at Aespala. He has been practicing cosmetic surgery since 1987.

Dr. Marschall was previously a faculty member in the Division of Plastic Surgery at the University of Illinois at Chicago for 7 years and is also a Diplomat of The American Board of Plastic Surgery, a member of The American Society of Plastic Surgeons, a member of The American Society for Aesthetic Plastic Surgery as well as many other reputable organizations.

Dr. Marschall's skill and expertise includes a wide variety of plastic surgery procedures, with a special emphasis on body contouring like tummy tuck (abdominoplasty), minimally invasive ProLipo™ laser liposuction, breast augmentation surgeries like breast implants, breast lifts and breast reductions, as well as the treatment of birth defects. He is also recognized for his work in facial aesthetic surgery, such as facelifts, eyelid lift (blepharoplasty), brow lift and rhinoplasty (nose job).

Aespala MedSpa and Plastic Surgery also offers additional body and face treatments such as Vanquish® Non-Surgical Fat Reduction, Laser Hair Removal and neck lifts. Botox® and a variety of dermal fillers are available including Juvéderm, Restylane, Voluma, Sculptra and Radiesse. Photofacials, Chemical Peels, HydraFacials, Micro-Needling, Dermaplaning, SkinTyte Laser Skin Tightening and Fractional Laser Skin Resurfacing are Aespala's advanced skin rejuvenation treatments. Spa treatments at Aespala include facials, waxing and hCG Medically Supervised Weight Loss.

To schedule a consultation with top Chicago plastic surgeons Dr. Michael Marschall or Dr. David Dreyfuss, or to learn more about medical spa services, call (630) 574 - 7777 or email jalessi(at)aespalamedspa(dot)com.

Read the full story at http://www.prweb.com/releases/2015/07/prweb12820211.htm

You May Also Be Interested In

• ParaZero Integrates its Safety Technology into Draganfly’s Commander 3XL Drones for Home Hospital Delivery and Emergency Response
• Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
• Deloitte's 14th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rebounds After Record Low